Clinical trial
Study of High-Dose Pulse Administration DN-101 (Calcitriol) in Patients With…
NCT00057031 · Novacea, Industry · Unknown status
Key facts
| NCT number | NCT00057031 |
|---|---|
| Title | Study of High-Dose Pulse Administration DN-101 (Calcitriol) in Patients With Myelodysplastic Syndrome (MDS) |
| Official title | A Phase 2, Multicenter, Open Label Study of the Safety and Efficacy of High-Dose Pulse Administration DN-101 (Calcitriol) in Patients With Myelodysplastic Syndrome |
| Lead sponsor | Novacea, Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Myelodysplastic Syndrome |
| Intervention type | Drug |
| Interventions | DN-101 (calcitriol) |
| Enrollment | 46 |
| Start date | Nov 1, 2002 |
| Completion | Mar 1, 2004 |
| First posted | Apr 1, 2003 |
| Last update posted | Nov 1, 2006 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: